Towa Pharmaceutical Co., Ltd. (TWAPF)
OTCMKTS
· Delayed Price · Currency is USD
25.33
+8.50 (50.51%)
At close: Jun 3, 2025
Towa Pharmaceutical Company Description
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan.
The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products.
It also offers IT service related to healthcare; and disease risk testing services. In addition, the company is involved with research and development of diagnostic drugs; and planning, development and OEM manufacturing of health food, pharmaceuticals, general food and other products.
The company was founded in 1951 and is headquartered in Osaka, Japan.
Towa Pharmaceutical Co., Ltd.
Country | Japan |
Founded | 1951 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 4,588 |
CEO | Itsuro Yoshida |
Contact Details
Address: 2-11, Shinbashi-cho Osaka, 571-8580 Japan | |
Phone | 81 6 6900 9100 |
Website | towayakuhin.co.jp |
Stock Details
Ticker Symbol | TWAPF |
Exchange | OTCMKTS |
Stock Type | Common Stock |
Fiscal Year | April - March |
Reporting Currency | JPY |
ISIN Number | JP3623150004 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Itsuro Yoshida | President and Representative Director |
Shiro Hatagami | Executive Officer and GM of Accounting and Finance Division |
Norikazu Inoue | Executive Officer and GM of Administration Division |
Shigeki Fujita | Operating Officer and GM of Human Resource Development Center |
Masao Tanaka | Director |
Tetsuro Tabata | Senior Executive Officer and GM of Production Division |
Takeshi Sugiura | Executive Officer |
Yasuyuki Oishi | Executive Officer |